Chronic Respiratory Disease
ISSN 1479-9723 · SAGE Publishing · United Kingdom · active 2004–2026
Metrics
- Scimago quartile (2025)
- Q2
- Cites per paper (2y)
- 3.3
- SJR
- 0.811
- h-index
- 66
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric (how the two differ). Citation rates differ enormously between fields, so compare within a discipline. What the other figures mean: journal quartile, SJR, h-index and article processing charge.
Data as of 8 November 2026 (venue index build).
Scimago Journal Rank 2025
In the Scimago Journal Rank 2025 edition, Chronic Respiratory Disease is Q2 in Pulmonary and Respiratory Medicine (#52 of 164 journals).
| Subject category | Quartile | Rank in category |
|---|---|---|
| Pulmonary and Respiratory Medicine | Q2 | #52 of 164 |
- Cites per document (2 years, Scopus)
- 2.66
- Documents indexed in 2025 (Scopus)
- 49
The quartile is the one Scimago prints for each category. Rank is the journal's position by SJR among the journals Scimago lists in that category (#1 is the highest); “—” means we hold no rank consistent with that quartile. The document count is what Scopus indexed that year, which can be lower than a journal's full output. Source: SCImago Journal Rank 2025 edition, from Scopus data (scimagojr.com, CC BY-NC).
Chronic Respiratory Disease is Q2 in Pulmonary and Respiratory Medicine (2025 edition, #52 of 164 journals), with SJR 0.811 (Scimago) and an h-index of 66 (OpenAlex). Listed in DOAJ, Scopus, Web of Science, PubMed.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Responding time
- Submission to publication
- ~11 wkDOAJ self-reported
Turnaround figures are indicative, not a guarantee: DOAJ values are self-reported by the journal (average weeks, submission to publication); library estimates are medians of the received/accepted dates printed in papers we hold. Editorial times vary by article type and season — confirm on the journal’s own site.
Indexing & access
- Indexed in
- DOAJScopusWeb of SciencePubMed
- Access status:
- gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
- Article processing charge
- Article processing charge (APC): $2,650 per accepted article (DOAJ). Fee waivers are available.
Scope
Frequently asked
Is Chronic Respiratory Disease a predatory journal?
Our screening does not flag Chronic Respiratory Disease. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.
Is Chronic Respiratory Disease indexed in Scopus or Web of Science?
Per our venue index, Chronic Respiratory Disease appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Chronic Respiratory Disease?
Papers in Chronic Respiratory Disease are cited about 3.3 times each within two years of publication, and Scimago places it in Q2, with an h-index of 66. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Chronic Respiratory Disease (Q1, Q2, Q3, or Q4)?
In the Scimago Journal Rank 2025 edition, Chronic Respiratory Disease is Q2 in Pulmonary and Respiratory Medicine (#52 of 164 journals). Quartiles split the journals in a subject category into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Chronic Respiratory Disease is cited about 3.3 times per paper over two years, with an h-index of 66.
What is the Web of Science (JCR) quartile of Chronic Respiratory Disease?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Chronic Respiratory Disease. The open equivalent is its Scimago quartile, Q2, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Chronic Respiratory Disease open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
What is the article processing charge (APC) to publish in Chronic Respiratory Disease?
Article processing charge (APC): $2,650 per accepted article (DOAJ). Fee waivers are available. The exact charge can vary by article type and any fee waiver, so confirm the current amount on the journal's own site.
How long does Chronic Respiratory Disease take to publish a paper?
Submission to publication for Chronic Respiratory Disease takes about ~11 wk — DOAJ self-reported. Treat it as indicative rather than a guarantee: editorial times vary by article type, reviewer availability and season, and a self-reported figure is the journal's own. We do not hold a peer-review acceptance rate for Chronic Respiratory Disease.
Ready to submit? Tools for your next paper
Similar venues
- Journal of Applied PhysiologyQ1 · American Physiological Society
- Therapeutic Advances in Respiratory DiseaseQ1 · SAGE Publishing
- HistopathologyQ1 · Wiley
- Pulmonary Pharmacology & TherapeuticsQ2 · Elsevier BV
- Photodiagnosis and Photodynamic TherapyQ2 · Elsevier BV
- Medicina Intensiva (English Edition)— · Elsevier BV
Compare it with its peers: Ranked Pulmonary and Respiratory Medicine journals — ranked by Scimago quartile and cites per paper, predatory venues excluded.